| Bioactivity | (Rac)-Lisaftoclax ((Rac)-APG-2575) is a Bcl-2 inhibitor that can be uesd for hematologic malignancy research (CN112898295A)[1]. | ||||||||||||
| Name | (Rac)-Lisaftoclax | ||||||||||||
| CAS | 2651980-10-6 | ||||||||||||
| Formula | C45H48ClN7O8S | ||||||||||||
| Molar Mass | 882.42 | ||||||||||||
| Appearance | 固体 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Yifan Zhai, et al. N- (phenylsulfonyl) benzamides and related compounds as BCL-2 inhibitors. CN112898295A. |
(Rac)-Lisaftoclax
CAS: 2651980-10-6 F: C45H48ClN7O8S W: 882.42
(Rac)-Lisaftoclax ((Rac)-APG-2575) is a Bcl-2 inhibitor that can be uesd for hematologic malignancy research (CN11289829
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.